Subscribe
Anusorn_Nakdee / Shutterstock.com
9 July 2024NewsBiotechnologyLiz Hockley

BlueAllele says rival gained $100m from Regeneron deal using patented tech

Minnesota-based biotech firm says Intellia used its patented gene editing innovations | Regeneron paid Intellia $100m for R&D that infringed three patents, alleges BlueAllele.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
The new IP battleground in CRISPR-Cas
21 November 2023   Recent clashes over patents covering modified guide RNAs have exposed different approaches from the US and Europe—and new complications for the field, says Claire Irvine of HGF.
CRISPR
Ricoh strengthens US unit with CRISPR gene editing licence
14 March 2024   Japanese imaging and electronics firm has acquired non-exclusive licence from ERS Genomics | Technology will be used by Elixirgen Scientific, acquired by Ricoh in 2022.


Editor's picks

Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024

Editor's picks

Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024

More on this story

Biotechnology
The new IP battleground in CRISPR-Cas
21 November 2023   Recent clashes over patents covering modified guide RNAs have exposed different approaches from the US and Europe—and new complications for the field, says Claire Irvine of HGF.
CRISPR
Ricoh strengthens US unit with CRISPR gene editing licence
14 March 2024   Japanese imaging and electronics firm has acquired non-exclusive licence from ERS Genomics | Technology will be used by Elixirgen Scientific, acquired by Ricoh in 2022.

More on this story

Biotechnology
The new IP battleground in CRISPR-Cas
21 November 2023   Recent clashes over patents covering modified guide RNAs have exposed different approaches from the US and Europe—and new complications for the field, says Claire Irvine of HGF.
CRISPR
Ricoh strengthens US unit with CRISPR gene editing licence
14 March 2024   Japanese imaging and electronics firm has acquired non-exclusive licence from ERS Genomics | Technology will be used by Elixirgen Scientific, acquired by Ricoh in 2022.

More features

Regeneron targets almost 50 patents in suit against Sandoz
High-tech expert joins White & Case in US expansion plan
Ipsen files further suit against CSPC over pancreatic cancer drug generic
Court recommends $54m judgment in Abbott TM case
Federal Circuit denies rehearing in heart valve case
FTC endorses greater access to affordable biosimilars
‘Still on the outside’: UPC says Abbott PI not valid in Ireland
Samsung Biologics faces suit from Amgen over bone biosimilars